Jan 10, 2022 / 03:30PM GMT
Cory William Kasimov - JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
Great. Good morning, and once again, welcome to the 40th Annual, and unfortunately, second-time virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst. And it's my pleasure to introduce our next company to present, which is Regeneron. Representing Regeneron are the company's cofounders, CEO, Len Schleifer; and CSO, George Yancopoulos.
Please note that following this presentation, we'll go right in to Q&A, where you can submit questions via the Ask a Question button on your conference portal and we'll work in as many as we can, time permitting.
So with that, let me turn things over to Len.
Leonard S. Schleifer - Regeneron Pharmaceuticals, Inc. - Co-Founder, President, CEO & Executive Director
Thanks, Cory. We've been getting introductions for 30 years, and that's one of the more stellar ones.
All kidding aside, we were hoping for something like live from New York, it's Regeneron.
Regeneron Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers